Concerns over the availability of influenza vaccines in Pakistan have drawn attention to the country’s vaccine procurement process, particularly the arrangements for people travelling for Hajj and Umrah. Federal Health Minister Syed Mustafa Kamal has been involved in discussions surrounding vaccine procurement and supply, while authorities examine concerns about the purchasing process.
According to recent media reports, a committee formed on the directives of Prime Minister Shehbaz Sharif reviewed the procurement of influenza and meningococcal vaccines by Border Health Services Pakistan. The committee recommended cancelling the existing procurement process and initiating a fresh one after identifying concerns about compliance with procurement requirements.
The matter has also raised questions about the cost of vaccination services. Reports said the previous arrangement cost approximately Rs1,250 per dose, while the newer arrangement was estimated at around Rs4,500 per person. The procurement process has also faced legal challenges from pharmaceutical companies that questioned its transparency and compliance with public procurement rules.
Meanwhile, ensuring the timely availability of vaccines remains important for protecting people against influenza and other preventable illnesses. Authorities will need to address procurement concerns while maintaining access to essential vaccination services for eligible travellers and the wider public.
The situation highlights the importance of transparent purchasing procedures, reasonable costs, and reliable vaccine supplies. Further clarification from the relevant authorities is needed to establish the current extent of any influenza vaccine shortage and the steps being taken to resolve it.
